UAVenture Capital

What UAVenture Capital does

UAVenture Capital (UAVC) is a private venture capital firm founded in 2012, headquartered in Tucson, Arizona with a regional office in Washington, DC. The firm invests at seed to growth stages in two thematic verticals: national security technologies (hypersonics, quantum communications, satellite infrastructure, advanced sensing, cybersecurity) and healthcare technologies (AI-powered diagnostics, blood storage systems, neuromodulation, non-opioid therapeutics, ophthalmic devices, intramedullary fixation). Its core differentiator is a strategic partnership model that combines capital with commercialization infrastructure — including an exclusive IP-sourcing arrangement with the University of Arizona Tech Transfer office and a co-development alliance with Critical Infrastructure Investments (CII), a government contracting firm with $30B in awarded contracts — to navigate highly regulated procurement and clinical pathways.

UAVC's portfolio currently spans approximately 14 active companies plus prior investments, including FreeFall Aerospace (LEO/MEO antenna systems with NASA CubeSat flight heritage), Delta Development (cold-chain blood storage used by an estimated 80% of new U.S. pre-hospital blood programs), StimAire (FDA Breakthrough-designated injectable sleep apnea treatment), iCRx (one-minute automated refractive eye exam), MediCarbone (carbon-fiber intramedullary nailing), Regulonix (non-opioid NaV1.7-targeted pain therapeutics with NIH licensing), CodeLucida (FAID error-correction IP for flash storage), EARDG Photonics (AR optics), DeUVe and CMLaser (defense/medical laser technologies), FreeStar5G (mmWave 5G antennas via a Spring 2020 joint venture with ED2 Corporation), CarboShield (carbon-fiber infrastructure repair), and Post.Bid.Ship (freight marketplace). The firm has recorded three successful exits, including a 32x return on a $4M investment yielding a $130M exit and a 7x exit on EARDG Photonics in 2021.

The business model is a classic venture capital fund structure: management fees on committed/invested capital plus carried interest on realized gains, with no disclosed pricing or product commercialization by UAVC itself. The leadership team — Fletcher McCusker (General Principle, founder of publicly traded Providence Service Corporation), Micheal Deitch (Managing Partner, founding CFO at SinfoníaRx and Providence with 30+ closed acquisitions and IPO experience), and David DiCosola (Managing Partner, U of A Tech Transfer commercialization lead) — provides operating bench depth atypical for a sub-50-person fund. Notable 2025 portfolio signals include Delta Development's $1.57M AFWERX Special Operations TACFI award and StimAire's MedTech Startup of the Year recognition, indicating continued capital deployment and milestone progression rather than step-change fund growth.

Name

UAVenture Capital

Legal name

UA Venture Capital

Website

https://uaventurecap.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

UAVenture Capital is a Tucson-based venture capital firm investing seed-to-growth capital in national security and healthcare technologies, leveraging an exclusive University of Arizona IP pipeline and a strategic partnership with defense contractor CII to commercialize portfolio companies.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Corporate Strategic Real Assets & Infrastructure Venture Investing (FSANAHAN)

Keywords

• Venture capital services
• National security investing
• Healthcare technology investing
• Early-stage equity funding
• Growth-stage capital

Headquarters

HQ city

Tucson

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Marketing channels2 records

Core offering

UAVenture Capital is a venture capital firm that provides seed-to-growth stage equity investment and strategic partnership to companies developing transformative national security and healthcare technologies. The firm combines capital deployment with hands-on mentorship, regulatory navigation support, and institutional access to government agencies, defense primes, health systems, and the University of Arizona IP pipeline. Beyond funding, UAVC actively supports portfolio companies through commercialization, contract capture, and pathway acceleration into DoD and healthcare markets.

Product overview

UAVenture Capital is a venture capital firm that supports seed- to growth-stage national security and healthcare technologies. The firm provides strategic partnership and capital to portfolio companies rather than operating a unified product platform. Their portfolio spans multiple technology domains including advanced medical devices (MediCarbone, Delta Development, StimAire, iCRx), biotechnology (Regulonix), telecommunications infrastructure (FreeStar5G, FreeFall Aerospace), laser technology (DeUVe, CMLaser), data storage (CodeLucida), infrastructure repair (CarboShield), and augmented reality (EARDG Photonics). The company operates from Arizona and Washington, DC offices.

Differentiator

Problem solved

Functional benefit

Products and services

• Seed-to-Growth Stage Venture Capital Investment Equity capital investment at seed and growth stages for startups developing national security technologies (hypersonics, advanced sensing, quantum communications, satellite infrastructure, cybersecurity, etc.) and healthcare technologies (AI-powered diagnostics, therapeutics, blood health, medical devices, telemedicine). Designed for founders and early-stage companies seeking capital plus strategic commercialization support.
• Strategic Partnership and Commercialization Support

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• Critical Infrastructure Investments (CII)coreStrategic or Co-development PartnerUAVC maintains a strategic partnership with Critical Infrastructure Investments (CII), a consulting and private equity firm with 17 years of government contracting experience and $30B in awarded contracts. This partnership opens pathways for portfolio companies in systems engineering and agile manufacturing; IP strategy and tech roadmapping; strategic contract capture and compliance support; and access to classified projects and accelerated DoD pathways.
• University of ArizonacoreStrategic or Co-development PartnerExclusive connections within the University of Arizona, a top research university, provide UAVC with first access to game-changing IP. UAVC serves as commercialization partner for U of A Tech Transfer. David DiCosola serves as commercialization partner for U of A Tech Transfer.
• North American Science Associates (NAMSA)minorStrategic or Co-development PartnerMediCarbone has a partnership with NAMSA, the world's only 100% medical device-focused, full continuum Contract Research Organization, for development support.
• National Institutes of Health (NIH)coreStrategic or Co-development PartnerRegulonix is collaborating on an exclusive license with the NIH, having identified four pre-clinical candidates for advancement into clinical trials.
• ED2 CorporationcoreStrategic or Co-development PartnerFreeFall Aerospace and ED2 Corporation formed FreeFall 5G in Spring 2020 to accelerate 5G deployment, bringing experienced personnel and world-class experts in antenna design, electrical engineering, and RF systems.
• NASAminorStrategic or Co-development PartnerFreeFall's patented antenna systems were successfully integrated and deployed into space on a NASA CubeSat Launch Initiative.
• U.S. Air Force / AFWERXcoreStrategic or Co-development PartnerDelta Development was awarded approximately $1.57M for a Special Operations TACFI opportunity to advance its Total Blood System (TBS) technology in partnership with the U.S. Air Force and AFWERX.
• Arizona Technology CouncilminorStrategic or Co-development PartnerFreeFall Aerospace is an active member of the Arizona Technology Council and participates in educational programs for youth in STEM with SheTech, TenWest, SARSEF, WISE, and the Metropolitan Education Commission.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• In-Q-Tel: The CIA-founded strategic venture firm investing in national security, defense, and dual-use technologies. In-Q-Tel is the most direct comparable to UAVC given its focus on national-security-aligned technologies, government procurement pathways, and seed-to-growth-stage investing — though it operates at materially larger scale.
• DCVC (Defense and Cybersecurity Venture Capital): Deep-tech VC focused on computational, materials, and defense technologies derived from frontier research. DCVC overlaps with UAVC in seed-to-growth-stage investing in national security, advanced sensing, and university-sourced deep-tech IP, with a similarly science-forward thesis.
• Lux Capital: Science and technology VC investing in frontier areas including space, healthcare, semiconductors, and defense. Lux's research-driven sourcing model and category depth in healthcare/biotech and aerospace mirrors UAVC's two-vertical thesis, though at materially larger fund size.

Broad incumbents

• Founders Fund: Established multi-stage VC with material exposure to defense (Anduril, Palantir) and healthcare. While significantly larger and broader in mandate, Founders Fund competes for similar deep-tech national security and biotech deals that UAVC targets.
• Khosla Ventures: Large early-stage VC with deep healthcare and frontier-tech practices. Overlaps with UAVC in seed-stage biotech, medical devices, and AI diagnostics, though Khosla's portfolio is materially larger and more diversified across consumer and enterprise.
• Andreessen Horowitz (a16z): Mega-fund with dedicated bio/health and American Dynamism (defense/industrial) practices. a16z is increasingly competing for the same university-sourced deep-tech IP and dual-use national security deals that anchor UAVC's thesis, but at fundamentally different scale.
• Bessemer Venture Partners: Heritage multi-stage VC with healthcare and aerospace practices. Overlaps with UAVC on early-stage healthcare (medical devices, biotech) and selected aerospace/defense adjacencies, though BVP's mandate is broader and stage-flexible.

Regional players

• Desert Angels: Arizona-based angel investing group focused on Southwest U.S. early-stage deals. Operates in the same regional ecosystem as UAVC and frequently co-invests in University of Arizona-sourced opportunities.
• Arizona Technology Investors: Regional Arizona angel network investing in early-stage companies across the state. Comparable to UAVC in geographic focus and seed-stage discipline, though without the national security or healthcare specialization.
• Sand Hill Angels: Silicon Valley-based angel group providing seed capital and operating support to early-stage companies. Comparable to UAVC's hands-on mentoring and seed-stage posture, but with a different regional ecosystem and broader sector mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments16 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UAVenture Capital